Hospital
Olean General Hospital
Olean General Hospital was paid $22.91M by Medicaid between Jan 2018 and Dec 2024, across 307 billing codes. Its largest line is 99283, emergency room visit (moderate) — 21% of everything it billed.
33Billing provider infoOLEAN GENERAL HOSPITAL
OLEAN, NY 14760
OLEAN, NY 14760
33aNPI1225083074assigned 05/23/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$22.91M
24GClaims666,230
24DCodes billed307
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#57 of 231
Median peer was paid$561K
This provider vs. median41×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,081 | $218K | |
| 2019 | 55,521 | $1.80M | |
| 2020 | 111,386 | $3.43M | |
| 2021 | 134,846 | $4.34M | |
| 2022 | 132,283 | $5.47M | |
| 2023 | 129,928 | $4.63M | |
| 2024incomplete | 96,185 | $3.03M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 24,980 | 22,751 | $4.88M |
| 96361 | Intravenous infusion, hydration; each additional hour | 6.7% | 10,884 | 7,483 | $1.54M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.5% | 6,080 | 5,744 | $1.27M |
| 80053 | Comprehensive metabolic panel | 4.4% | 45,783 | 39,925 | $1.01M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.0% | 4,249 | 4,094 | $920K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 3.8% | 11,311 | 3,272 | $864K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.1% | 3,268 | 3,170 | $706K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.9% | 3,361 | 3,231 | $659K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.4% | 2,314 | 2,250 | $551K |
| D1110 | Prophylaxis - adult | 2.2% | 9,722 | 8,862 | $495K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.2% | 7,870 | 7,152 | $494K |
| G0378 | Hospital observation service, per hour | 1.7% | 2,026 | 1,100 | $389K |
295 more codes
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.7% | 2,033 | $387K |
| D0120 | Dental checkup, returning patient | 1.6% | 12,235 | $364K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.5% | 2,453 | $347K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.5% | 1,377 | $346K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.5% | 1,770 | $342K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.4% | 2,876 | $311K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.0% | 8,464 | $238K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 978 | $221K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,379 | $204K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 5,141 | $203K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 269 | $201K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 555 | $172K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 2,004 | $171K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 16,973 | $166K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 6,109 | $154K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 6,110 | $145K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 5,402 | $143K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,683 | $143K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 2,784 | $142K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 44,611 | $139K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,775 | $138K |
| D0274 | Bitewings - four radiographic images | <1% | 5,124 | $136K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,419 | $133K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,829 | $125K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 9,985 | $124K |
| 80061 | Lipid panel | <1% | 15,410 | $119K |
| D1120 | Dental cleaning, child | <1% | 2,747 | $110K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 3,879 | $102K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 1,595 | $96K |
| D0330 | Panoramic radiographic image | <1% | 2,714 | $94K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,504 | $91K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,539 | $90K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 307 | $89K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 4,299 | $89K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,787 | $88K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,997 | $86K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 2,741 | $84K |
| 83880 | <1% | 3,325 | $83K | |
| 82607 | <1% | 6,142 | $76K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 898 | $74K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 10,931 | $69K |
| 86850 | <1% | 2,632 | $69K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 185 | $66K |
| 20610 | <1% | 1,249 | $60K | |
| 97161 | <1% | 773 | $59K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 2,137 | $54K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 718 | $53K |
| 87088 | <1% | 8,571 | $53K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,936 | $53K |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 803 | $49K |
| 87390 | <1% | 2,310 | $48K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,810 | $47K |
| 99223 | Prolong inpt eval add15 m | <1% | 354 | $46K |
| D0140 | Limited oral evaluation - problem focused | <1% | 2,300 | $45K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,039 | $45K |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 3,087 | $44K |
| D0220 | Intraoral - periapical first radiographic image | <1% | 3,023 | $43K |
| 84439 | <1% | 4,873 | $42K | |
| 82728 | <1% | 3,024 | $38K | |
| 73221 | <1% | 120 | $37K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,080 | $36K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,375 | $36K |
| 59025 | Fetal non-stress test | <1% | 1,254 | $36K |
| 87070 | <1% | 3,979 | $36K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 715 | $35K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 544 | $34K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,113 | $33K |
| 87077 | <1% | 4,547 | $31K | |
| 83655 | <1% | 2,414 | $31K | |
| 82746 | <1% | 2,548 | $30K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 790 | $28K |
| 86900 | <1% | 2,779 | $28K | |
| 84153 | <1% | 1,548 | $27K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 99 | $26K |
| 86901 | <1% | 2,751 | $24K | |
| 93017 | <1% | 279 | $24K | |
| 85610 | <1% | 8,712 | $23K | |
| 81003 | <1% | 18,656 | $23K | |
| 87275 | <1% | 4,699 | $23K | |
| 87186 | <1% | 3,769 | $22K | |
| 93971 | <1% | 366 | $22K | |
| 88304 | <1% | 602 | $22K | |
| 72110 | <1% | 982 | $21K | |
| 73562 | <1% | 1,013 | $21K | |
| 84403 | <1% | 791 | $20K | |
| D0210 | Intraoral - complete series of radiographic images | <1% | 997 | $20K |
| 81025 | <1% | 2,295 | $20K | |
| 83735 | <1% | 9,912 | $19K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 210 | $19K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 10,325 | $19K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 7,878 | $19K |
| 71045 | Radiologic examination, chest; single view | <1% | 5,054 | $19K |
| 86756 | <1% | 1,578 | $18K | |
| 76536 | <1% | 513 | $17K | |
| 73610 | <1% | 1,161 | $16K | |
| 70486 | <1% | 243 | $16K | |
| 73030 | <1% | 1,574 | $16K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,903 | $15K |
| 82043 | <1% | 3,012 | $15K | |
| 86803 | <1% | 1,487 | $15K | |
| 83540 | <1% | 2,981 | $15K | |
| 85027 | <1% | 4,143 | $15K | |
| 86141 | <1% | 1,638 | $15K | |
| 86376 | <1% | 1,039 | $15K | |
| 73564 | <1% | 801 | $13K | |
| 84702 | <1% | 1,491 | $13K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 165 | $13K |
| 82570 | <1% | 2,748 | $13K | |
| 82784 | <1% | 951 | $13K | |
| 84436 | <1% | 2,354 | $13K | |
| 73110 | <1% | 784 | $12K | |
| 86769 | <1% | 373 | $12K | |
| 73630 | <1% | 1,083 | $11K | |
| 86038 | <1% | 1,708 | $11K | |
| 29581 | <1% | 177 | $11K | |
| 82803 | <1% | 310 | $11K | |
| D0272 | Bitewings - two radiographic images | <1% | 609 | $11K |
| 74018 | <1% | 929 | $10K | |
| 83550 | <1% | 1,816 | $10K | |
| 73130 | <1% | 844 | $10K | |
| 84703 | <1% | 3,957 | $9K | |
| 70496 | <1% | 41 | $9K | |
| 87340 | <1% | 1,177 | $9K | |
| 84466 | <1% | 700 | $8K | |
| 86039 | <1% | 1,276 | $8K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 53 | $8K |
| 86800 | <1% | 599 | $8K | |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 76 | $7K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 61 | $7K |
| 72141 | <1% | 25 | $7K | |
| 71271 | <1% | 171 | $7K | |
| 82962 | <1% | 2,335 | $7K | |
| 85652 | <1% | 3,458 | $7K | |
| 85730 | <1% | 5,829 | $6K | |
| 86762 | <1% | 669 | $6K | |
| 86618 | <1% | 435 | $6K | |
| 76830 | Ultrasound, transvaginal | <1% | 148 | $6K |
| 87276 | <1% | 4,671 | $6K | |
| 95812 | <1% | 63 | $6K | |
| 83615 | <1% | 1,289 | $6K | |
| 80329 | <1% | 2,445 | $6K | |
| 86140 | <1% | 1,701 | $6K | |
| 72131 | <1% | 62 | $6K | |
| D2150 | Silver amalgam - two surfaces, primary or permanent | <1% | 55 | $6K |
| 76641 | <1% | 153 | $6K | |
| 84146 | <1% | 277 | $5K | |
| 86255 | <1% | 716 | $5K | |
| 87081 | <1% | 979 | $5K | |
| 83690 | <1% | 4,862 | $5K | |
| D2331 | <1% | 56 | $5K | |
| 86003 | <1% | 94 | $5K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 25 | $4K |
| 83525 | <1% | 388 | $4K | |
| 84402 | <1% | 159 | $4K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 39 | $4K |
| 82150 | <1% | 2,415 | $4K | |
| 73502 | <1% | 402 | $4K | |
| 84484 | <1% | 6,884 | $3K | |
| 84481 | <1% | 335 | $3K | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 83 | $3K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 13 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,376 | $3K |
| 84550 | <1% | 797 | $3K | |
| 87430 | <1% | 1,470 | $3K | |
| 83001 | <1% | 170 | $3K | |
| 86592 | <1% | 1,106 | $3K | |
| 97010 | <1% | 422 | $3K | |
| 72050 | <1% | 186 | $3K | |
| 12001 | <1% | 12 | $3K | |
| 86787 | <1% | 322 | $3K | |
| 99442 | <1% | 68 | $3K | |
| 86665 | <1% | 118 | $3K | |
| 83970 | <1% | 71 | $2K | |
| 86235 | <1% | 123 | $2K | |
| 99406 | <1% | 50 | $2K | |
| 90715 | <1% | 125 | $2K | |
| 86430 | <1% | 437 | $2K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 38 | $2K |
| 87040 | <1% | 2,731 | $2K | |
| 82977 | <1% | 433 | $2K | |
| 85379 | <1% | 1,584 | $2K | |
| 96367 | <1% | 47 | $2K | |
| 83605 | <1% | 4,714 | $2K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 189 | $2K |
| 87205 | <1% | 843 | $2K | |
| 83002 | <1% | 91 | $2K | |
| 86617 | <1% | 119 | $2K | |
| 87522 | Neg quan hep c or qual rna | <1% | 37 | $2K |
| 72100 | <1% | 106 | $1K | |
| 84145 | <1% | 1,685 | $1K | |
| 82550 | <1% | 1,207 | $1K | |
| D1351 | Sealant - per tooth | <1% | 12 | $1K |
| 93880 | <1% | 12 | $1K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 45 | $1K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 24 | $1K |
| 82247 | <1% | 119 | $1K | |
| 87075 | <1% | 266 | $1K | |
| 82553 | <1% | 622 | $1K | |
| 86160 | <1% | 60 | $1K | |
| 84156 | <1% | 334 | $1K | |
| 86664 | <1% | 85 | $1K | |
| 96376 | <1% | 2,308 | $1K | |
| 86706 | <1% | 123 | $1K | |
| 82533 | <1% | 72 | $1K | |
| 80074 | <1% | 28 | $1K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 136 | $1K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 91 | $1K |
| 99441 | <1% | 40 | $947.78 | |
| 70498 | <1% | 29 | $906.29 | |
| 76857 | <1% | 18 | $852.87 | |
| 84480 | <1% | 106 | $818.39 | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 13 | $797.81 |
| 82248 | <1% | 221 | $728.83 | |
| 81002 | <1% | 366 | $714.18 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 261 | $707.87 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 7,577 | $700.66 |
| 82950 | <1% | 137 | $689.81 | |
| 86480 | <1% | 14 | $663.00 | |
| 88112 | <1% | 12 | $651.49 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 7,509 | $622.83 |
| 72114 | <1% | 19 | $612.02 | |
| 83516 | <1% | 45 | $584.59 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,643 | $574.44 |
| 83090 | <1% | 30 | $525.94 | |
| 84100 | <1% | 186 | $511.66 | |
| 90686 | <1% | 67 | $509.65 | |
| 95816 | <1% | 13 | $500.52 | |
| 83921 | <1% | 26 | $492.81 | |
| 85007 | <1% | 271 | $489.32 | |
| 86780 | <1% | 46 | $483.24 | |
| 86705 | <1% | 43 | $443.91 | |
| 80076 | <1% | 54 | $440.22 | |
| 73080 | <1% | 60 | $427.19 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,638 | $411.35 |
| D1206 | Topical application of fluoride varnish | <1% | 13 | $390.00 |
| 87427 | <1% | 38 | $367.66 | |
| 82670 | <1% | 13 | $343.05 | |
| 86225 | <1% | 43 | $308.65 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 12 | $297.00 |
| 97014 | <1% | 30 | $289.42 | |
| 84479 | <1% | 73 | $285.16 | |
| 87045 | <1% | 38 | $272.06 | |
| 86328 | <1% | 15 | $271.38 | |
| 84144 | <1% | 13 | $267.82 | |
| 72072 | <1% | 13 | $227.82 | |
| 87803 | <1% | 27 | $227.09 | |
| 87209 | <1% | 25 | $212.58 | |
| 73100 | <1% | 15 | $212.04 | |
| 82105 | <1% | 18 | $193.42 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 29 | $191.56 |
| 87449 | <1% | 26 | $173.47 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,380 | $171.31 |
| 83993 | <1% | 12 | $161.51 | |
| 83010 | <1% | 13 | $144.79 | |
| 83520 | <1% | 12 | $143.23 | |
| 72220 | <1% | 14 | $132.46 | |
| 84460 | <1% | 27 | $125.97 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,288 | $111.07 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,369 | $109.98 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 677 | $89.42 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 147 | $83.64 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 261 | $60.04 |
| 87046 | <1% | 12 | $54.22 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,846 | $53.41 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 662 | $51.92 |
| 86308 | <1% | 24 | $49.20 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,694 | $44.27 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 484 | $42.44 |
| 74019 | <1% | 12 | $34.94 | |
| 73590 | <1% | 13 | $32.12 | |
| J3490 | Unclassified drugs | <1% | 266 | $26.14 |
| 82947 | <1% | 12 | $25.25 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 164 | $21.27 |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 33 | $18.99 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 779 | $15.45 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 155 | $12.75 |
| 87073 | <1% | 18 | $8.78 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 372 | $8.02 |
| J1815 | Injection, insulin, per 5 units | <1% | 62 | $5.40 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 32 | $3.27 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 291 | $1.55 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 727 | $1.19 |
| 82009 | <1% | 18 | $1.08 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 0% | 799 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 223 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 34 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 58 | $0.00 |
| D0190 | 0% | 13 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 14 | $0.00 |
| 99222 | Initial hospital care, per day, moderate complexity | 0% | 17 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 26 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 442 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 143 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 57 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOWENS, JILL (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Olean General Hospital | Bradford, PA | $3.17M |
| Health System Physician PC | Olean, NY | $945K |
| Olean General Hospital | Bradford, PA | $349K |
| Olean General Hospital | Olean, NY | $130K |
| Olean General Hospital | Bradford, PA | $59K |
| Olean General Hospital | Bradford, PA | $23K |
| Olean General Hospital | Smethport, PA | $18K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.